🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care

RecruitingNAAges 18 Years - anyAllUniversity Hospital Muenster
NCT06648733 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The transition of palliative care patients from inpatient to outpatient care is aimed to be improved through structured pharmaceutical discharge management by a trained pharmacist. This data will be compared with retrospective cases.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: All individual indications for general and specialised palliative care as part of routine clinical practice (e.g.): * advanced, malignant tumour disease * advanced, chronic obstructive pulmonary disease * Patients with advanced disease and limited life expectancy (approx. 12 months) Further care in the SOPC Muenster (prospective data) Sufficient understanding of the German language to be able to understand the information and consent form Exclusion Criteria: Impossibility of understanding the information and declaration of consent.
💊

What it tests

  • Structured pharmaceutical discharge management
📍

Where

1 site
University Hospital Muenster
Münster, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy